---
title: "Astrazeneca: In the BAXHTN Phase III trial, baxdrostat resulted in a clinically significant reductio"
description: "Astrazeneca: In the BAXHTN Phase III trial, baxdrostat resulted in a clinically significant reduction in patients' systolic blood pressure. Astrazeneca will apply for approval for this drug by the end"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255314923.md"
published_at: "2025-08-30T14:16:00.000Z"
---

# Astrazeneca: In the BAXHTN Phase III trial, baxdrostat resulted in a clinically significant reductio

> Astrazeneca: In the BAXHTN Phase III trial, baxdrostat resulted in a clinically significant reduction in patients' systolic blood pressure. Astrazeneca will apply for approval for this drug by the end of the year

Astrazeneca: In the BAXHTN Phase III trial, baxdrostat resulted in a clinically significant reduction in patients' systolic blood pressure. Astrazeneca will apply for approval for this drug by the end of the year

### Related Stocks

- [AZN.US - AstraZeneca](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Trump Strikes Again: AstraZeneca's Surprise Drug Deal Could Shake Big Pharma's Global Pricing Power | AstraZeneca has reached a drug-pricing deal with President Trump to reduce Medicaid drug prices, potentially reshaping B | [Link](https://longbridge.com/en/news/260941568.md) |
| ANALYSIS-AstraZeneca's US listing may pull other firms from London in its wake | AstraZeneca's decision to upgrade its U.S. listing while retaining its London presence may influence other UK firms to c | [Link](https://longbridge.com/en/news/259563996.md) |
| ConocoPhillips considers selling Permian assets worth $2 billion, Bloomberg News reports | Feb 20 (Reuters) - ConocoPhillipsis exploring a sale of some of its Permian Basin assets as part of a broader streamlini | [Link](https://longbridge.com/en/news/276478732.md) |
| IronBridge Private Wealth LLC Has $905,000 Holdings in Apple Inc. $AAPL | IronBridge Private Wealth LLC reduced its stake in Apple Inc. (NASDAQ:AAPL) by 77.3% in Q3, holding 3,555 shares valued  | [Link](https://longbridge.com/en/news/276436345.md) |
| Financial Advocates Investment Management Lowers Stock Position in Meta Platforms, Inc. $META | Financial Advocates Investment Management reduced its stake in Meta Platforms, Inc. by 66.7% in Q3, now holding 2,343 sh | [Link](https://longbridge.com/en/news/276432394.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
